- Home
- BMRN vs UHS Comparison
BMRN vs UHS Comparison
Compare BMRN & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- UHS
- Stock Information
- Founded
- BMRN 1996
- UHS 1978
- Country
- BMRN United States
- UHS United States
- Employees
- BMRN N/A
- UHS N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- UHS Hospital/Nursing Management
- Sector
- BMRN Health Care
- UHS Health Care
- Exchange
- BMRN Nasdaq
- UHS Nasdaq
- Market Cap
- BMRN 12.1B
- UHS 11.7B
- IPO Year
- BMRN 1999
- UHS N/A
- Fundamental
- Price
- BMRN $59.82
- UHS $183.75
- Analyst Decision
- BMRN Buy
- UHS Buy
- Analyst Count
- BMRN 22
- UHS 17
- Target Price
- BMRN $93.43
- UHS $222.31
- AVG Volume (30 Days)
- BMRN 1.6M
- UHS 840.2K
- Earning Date
- BMRN 05-01-2025
- UHS 04-28-2025
- Dividend Yield
- BMRN N/A
- UHS 0.43%
- EPS Growth
- BMRN 152.82
- UHS 51.30
- EPS
- BMRN 2.71
- UHS 17.80
- Revenue
- BMRN $2,950,227,000.00
- UHS $16,084,073,000.00
- Revenue This Year
- BMRN $12.27
- UHS $9.55
- Revenue Next Year
- BMRN $9.86
- UHS $5.42
- P/E Ratio
- BMRN $22.11
- UHS $10.47
- Revenue Growth
- BMRN 19.36
- UHS 9.73
- 52 Week Low
- BMRN $52.93
- UHS $153.99
- 52 Week High
- BMRN $94.85
- UHS $243.25
- Technical
- Relative Strength Index (RSI)
- BMRN 40.34
- UHS 56.74
- Support Level
- BMRN $60.92
- UHS $175.41
- Resistance Level
- BMRN $65.40
- UHS $175.92
- Average True Range (ATR)
- BMRN 1.96
- UHS 7.22
- MACD
- BMRN 0.06
- UHS 1.82
- Stochastic Oscillator
- BMRN 21.52
- UHS 87.70
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.